Conavi Medical Corp.
CNVIF
$0.13
$0.0213.68%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.14% | -40.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.14% | -40.22% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -2.14% | -40.22% | |||
| SG&A Expenses | -16.92% | -10.26% | |||
| Depreciation & Amortization | 50.31% | -2.40% | |||
| Other Operating Expenses | -- | -109.55% | |||
| Total Operating Expenses | 35.68% | -11.98% | |||
| Operating Income | -36.76% | 10.78% | |||
| Income Before Tax | -29.41% | -77.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.41% | -77.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.41% | -77.45% | |||
| EBIT | -36.76% | 10.78% | |||
| EBITDA | -35.56% | 11.00% | |||
| EPS Basic | -24.93% | -36.36% | |||
| Normalized Basic EPS | -19.03% | -43.04% | |||
| EPS Diluted | -24.93% | -36.36% | |||
| Normalized Diluted EPS | -19.03% | -43.04% | |||
| Average Basic Shares Outstanding | 3.61% | 30.15% | |||
| Average Diluted Shares Outstanding | 3.61% | 30.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||